Current controversies in the management of GIST
Room: Grand Ballroom
Chairs: John Zalcberg & Paul Burton
PROGRAM - DAY 1
THURSDAY 26 NOVEMBER 2026
| What's the role of surgical (or other ablation) for metastatic disease | Tim Underwood |
| Should the sequence of medical treatments for metastatic GIST be based on molecular analysis | Amitesh Roy |
| What's the optimal duration of adjuvant treatment for high-risk GIST in 2026 | Connie Diakos |
Room: Federation Concert Hall
Chairs: Paul Burton & Margaret Lee
Multi-Modality Treatment of Oesophageal and Gastric Adenocarcinoma
Room: Federation Concert Hall
Chairs: Margaret Lee (GCT) & Adam Frankel (AANZGOSA)
| Perioperative therapies in Oesophagogastric Adenocarcinoma: Achievements and the Path Ahead | Elena Elimova |
| The evolving role of Radiotherapy in Oesophagogastric Adenocarcinoma: Standard, Selective, or Sunset? | Trevor Leong |
| Surgical status 2026 – multimodality management of oesophageal adenocarcinoma and how surgery is finding a new role | Tim Underwood |
| Impact of nutritional status on oncological outcomes: How can we improve collaboration | Lisa Murnane |
| Panel Discussion |
Room: Federation Ballroom
Controversies and Debates: Evolving Perspectives and Emerging Consensus
Room: Federation Concert Hall
Part 1 Chairs: Cuong Duong & Chris Karapetis
| Can tailored, high quality or radical surgery or system design make the difference or is the die already cast? | Wendy Brown |
| Role of advanced endoscopic procedures including following neoadjuvant therapy | Alex Boussioutas |
| The oligometastatic frontier: Defining “resectable stage IV” | Tim Underwood |
| Peritoneal relapse in OG adenocarcinoma: OMEGCA update, are peritoneal-directed therapies ready for prime time? | David Liu |
| Panel discussion | Wendy Brown, Alex Boussioutas, Tim Underwood & David Liu |
Part 2 Presenters & Facilitators: Andew Barbour Amitesh Roy
| a. Opportunities for GCT to interface with AANZGOSA | Amitesh Roy |
| b. Opportunities for AANZGOSA to interface with GCT | Andrew Barbour |
| Panel discussion: Opportunities and potential trials (across disciplines & countries) | Sarah Thompson, Tim Underwood, Alex B, Trevor Leong & Elena Elimova |
Room: Federation Ballroom
New Opportunities for Addressing Old Problems
Room: Federation Concert Hall
Chairs: Andrew Barbour (AANZGOSA) & Mori Aghmesheh (GCT)
| Immunotherapeutic Opportunities in dMMR, pMMR Oesophago-gastric Adenocarcinoma | Elena Elimova |
| 2. The practical role of IO in locally advanced upper GI cancers with current indications in Australia | Ankit Jain |
| Treatment options for OGA in Aotearoa NZ | John Mak |
| When immunotherapy reshapes the surgical battlefield: how and when to survey, modalities of response, when has a cCR been achieved? | Tim Underwood |
| MDT cases & Panel discussion – MSI-H case | Ankit Jain (Facilitator) |
Room: Federation Ballroom
Super MDT: Where guidelines meet reality
Room: Federation Concert Hall
Chairs: Andrew Barbour (AANZGOSA) & TBC MO
| Presentation 1 UK National MDT | Tim Underwood |
| Presentation 2 Integrated cancer genomics clinic | Alex Boussioutas |
| 3 Cases | Panel Alex Boussioutas (Gastroenterologist), Tim Underwood & Iain Thompson (Surgery), Elena Emilove & Louise Nott (Oncology), Lisa Murnane (Dietitian) • Surgery: Tim Underwood, Iain Thompson • Oncology: Elena Elimova, Louise Nott • Dietitian: Lisa Murnane |
Room: Mezzanine Foyer
Lumina (Part of the Tasman Hotel)
12 Murray Street, Hobart
Purchase a Dinner Ticket HERE
PROGRAM - DAY 2
FRIDAY 27 NOVEMBER 2026
Advanced techniques in resectional surgery
Chairs: Cuong Duong & Rob Finch
| Double tract reconstruction | Tim Underwood |
| Challenges in the chest | Iain Thompson |
| Panel discussion: Questions and answers |
The 2026 Surgical Landscape of Oesophageal and Gastric carcinoma
Chairs: David Watson & Nick Evenett
| Translational research and its role in OG surgery | Tim Underwood |
| Neo-adjuvant therapy and oncological issues: What oncologists need from surgeons! | Margaret Lee |
| Barrett’s oesophagus screening, significance and new directions | Alex Boussioutas |
| Volume performance relationship and service delivery in AANZ Have we improved and what should service delivery look like | Ahmad Aly |
| Panel discussion on volume performance outcomes and service structure | Wendy Brown, Tim Underwood, Adam Frankel & Ahmad Aly |
Looking to the Future
Chairs: Mary-Ann Johnson & Iain Thompson
| 20 years of oesophageal surgery in Australia: Where will be in 2030 and beyond? | Mark Smithers (15) |
| Beyond the FLOT vs. CROSS Stalemate: trial data, real-world evidence and future directions | David Liu (12) |
| Patient and carer unmet needs | Cuong Duong (12) |
| The patient who is physiological ‘borderline’ for surgery what to do. What if they improve during treatment? | TBA |
| Patient centred and shared decision making | TBA |
| Panel Discussion |
AANZGOSA Free Papers
| 12:30 - 12:40 AGM |
Rapid Fire Posters
Exhibition/Catering Area
13:00 – 13:30 (Subject to updates)
Complex Issues
Chair: Manjunath Siddaiah-Subramanya
| President’s lecture Revisional hiatal surgery where are we at? | Sarah Thompson (25 mins) Chair: Paul Burton |
| RYGB versus fundoplication for reflux 15 | Adam Frankel |
| Where is bariatric surgery and what should AANZGOSA be doing about it? | Wendy Brown (15 mins) |
| Complex revisional surgery tips revising the gastric conduit and functional problems tips and tricks. | Tim Underwood (15 mins) |
| Panel Discussion |
Allied Health & Nursing
Lisa Murnane (Allied health)
| Mechanical and physiological consequences of oesophagogastric cancer resection | Iain Thompson |
| Immunotherapy in oesophagogastric cancer – the basics | Andrew Haydon |
| Management of immunotherapy-induced colitis and gastrointestinal side effects | Alex Boussioutas |
| Optimal treatment pathways and system design for oesophagogastric cancer management - lessons learned and future directions | Mark Smithers |
Room: Federation Ballroom
Do these problems only happen to me? Ask the experts
Chair: Michael Talbot
| Worst functional problems post fundoplication and how to avoid them | David Watson |
| Worst functional problems following bariatric operations. znd how to avoid them | Michael Talbot |
| Case presentations - AANZGOSA Fellows | Linda Tang, Yazmin Johari & David Tovmassian |
| Panel discussion: | Michael Talbot, David Watson, Kon Shimokawa, Tim Underwood & Alex Boussioutas |
Adam Frankel & Andrew Barbour
Executive Officer
